CWM »

Arrivent Biopharma shares owned by CWM

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by CWM from 13F filings

Historical chart of CWM investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by CWM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by CWM

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 94 21.28
2024-06-30 $1.0k 58 17.24

More positions owned by CWM

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Value Etf (EFV)
Pimco Etf Tr Active Bd Etf (BOND)
Spdr Ser Tr Portfolio S&p400 (SPMD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for CWM

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
Charles Schwab Investment Management

View all funds holding Arrivent Biopharma